Detalhe da pesquisa
1.
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.
Nat Immunol
; 22(1): 19-24, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208929
2.
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia.
Blood
; 140(1): 25-37, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507686
3.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Blood
; 139(5): 732-747, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653238
4.
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma.
Am J Hematol
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700035
5.
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma.
Blood
; 137(5): 637-645, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870269
6.
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
Am J Hematol
; 98(3): 449-463, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594167
7.
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.
Mol Ther
; 30(5): 1979-1993, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167974
8.
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma.
Blood
; 136(23): 2628-2637, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785666
9.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320921
10.
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Hematol Oncol
; 40(1): 11-21, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714558
11.
High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma.
Hematol Oncol
; 40(4): 541-553, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451108
12.
FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.
Hematol Oncol
; 36(1): 299-306, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771763
13.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28775121
14.
Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.
Haematologica
; 100(1): 77-86, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344523
15.
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.
Am J Hematol
; 88(12): 1062-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23940056
16.
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up.
Blood Adv
; 7(18): 5272-5280, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352266
17.
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659).
Oncotarget
; 14: 57-70, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702329
18.
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Blood Adv
; 7(16): 4435-4447, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276067
19.
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients.
Br J Haematol
; 156(4): 481-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22150204
20.
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Am J Hematol
; 87(9): 936-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22718434